Ginkgo Bioworks Holdings Inc (DNA)
10.08
+1.34
(+15.33%)
USD |
NYSE |
Dec 20, 16:00
10.08
0.00 (0.00%)
After-Hours: 20:00
Ginkgo Bioworks Holdings Shareholders Equity (Quarterly): 797.94M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Perspective Therapeutics Inc | 328.47M |
| Lexicon Pharmaceuticals Inc | 178.51M |
| Atara Biotherapeutics Inc | -90.54M |
| Corvus Pharmaceuticals Inc | 12.41M |
| Clearside Biomedical Inc | -34.79M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.481B |
| Total Liabilities (Quarterly) | 682.94M |
| Current Ratio | 5.790 |